These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6135606)

  • 81. The effect of pre- and post-treatment with phenobarbital on the extent of gamma-glutamyl transpeptidase positive foci induced in rat liver by N-nitrosomorpholine.
    Schwarz M; Bannasch P; Kunz W
    Cancer Lett; 1983 Nov; 21(1):17-21. PubMed ID: 6139159
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 83. 22-Oxa-1,25(OH)2vitamin D3, a synthetic analogue of vitamin D3, has no promoting activity in a rat liver medium-term bioassay.
    Otoshi T; Iwata H; Takada N; Nishisawa Y; Morii H; Fukushima S
    Cancer Lett; 1994 Aug; 83(1-2):69-74. PubMed ID: 8062235
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Trihalomethanes as initiators and promoters of carcinogenesis.
    Pereira MA; Lin LH; Lippitt JM; Herren SL
    Environ Health Perspect; 1982 Dec; 46():151-6. PubMed ID: 7151756
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Estrogen receptor levels and occupancy in hepatic sinusoidal endothelial and Kupffer cells are enhanced by initiation with diethylnitrosamine and promotion with 17alpha-ethinylestradiol in rats.
    Vickers AE; Lucier GW
    Carcinogenesis; 1996 Jun; 17(6):1235-42. PubMed ID: 8681437
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sequential histopathological analysis of hepatocarcinogenesis in rats during promotion with orotic acid.
    Denda A; Laconi E; Rao PM; Rajalakshmi S; Sarma DS
    Cancer Lett; 1994 Jul; 82(1):55-64. PubMed ID: 8033069
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of phenobarbital on diethylnitrosamine and dimethylnitrosamine induced hepatocellular tumors in male B6C3F1 mice.
    Klaunig JE; Weghorst CM; Pereira MA
    Cancer Lett; 1988; 42(1-2):133-9. PubMed ID: 3180032
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns.
    Kovalszky I; Szeberenyi S; Zalatnai A; Vincze I; Lapis K; Jeney A
    Carcinogenesis; 1992 May; 13(5):773-8. PubMed ID: 1350234
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of phenobarbital on the development of neoplastic lesions in the liver of cycasin-treated rats.
    Uchida E; Hirono I
    J Cancer Res Clin Oncol; 1981; 100(3):231-8. PubMed ID: 6115862
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Occurrence of progressive DNA damage coincident with the appearance of foci of altered hepatocytes.
    Stout DL; Becker FF
    Carcinogenesis; 1982; 3(6):599-602. PubMed ID: 6126282
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations.
    Ghia M; Mereto E
    Cancer Lett; 1989 Aug; 46(3):195-202. PubMed ID: 2569927
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 5-azacytidine potentiates initiation induced by carcinogens in rat liver.
    Denda A; Rao PM; Rajalakshmi S; Sarma DS
    Carcinogenesis; 1985 Jan; 6(1):145-6. PubMed ID: 2578334
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunohistochemical differentiation of gamma-glutamyltranspeptidase in focal lesions and in zone I of rat liver after treatment with chemical carcinogens.
    Fischer G; Lilienblum W; Ullrich D; Bock KW
    Carcinogenesis; 1986 Sep; 7(9):1405-10. PubMed ID: 2874897
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunohistochemical demonstration of decreased L-pyruvate kinase in enzyme altered rat liver lesions produced by different carcinogens.
    Fischer G; Domingo M; Lodder D; Katz N; Reinacher M; Eigenbrodt E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(6):359-64. PubMed ID: 2891220
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Carcinogenicity of chlorinated methane and ethane compounds administered in drinking water to mice.
    Klaunig JE; Ruch RJ; Pereira MA
    Environ Health Perspect; 1986 Nov; 69():89-95. PubMed ID: 3816740
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Epigenetic effects of liver tumor promoters and implications for health effects.
    Williams GM
    Environ Health Perspect; 1983 Apr; 50():177-83. PubMed ID: 6873012
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis.
    Dragan YP; Xu YD; Pitot HC
    Prev Med; 1991 Jan; 20(1):15-26. PubMed ID: 1672562
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Growth kinetics of enzyme-altered liver foci in rats treated with phenobarbital or alpha-hexachlorocyclohexane.
    Luebeck EG; Grasl-Kraupp B; Timmermann-Trosiener I; Bursch W; Schulte-Hermann R; Moolgavkar SH
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):304-15. PubMed ID: 7532877
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dose-response of promotion by polychlorinated biphenyls and chloroform in rat liver foci bioassay.
    Deml E; Oesterle D
    Arch Toxicol; 1987; 60(1-3):209-11. PubMed ID: 2887150
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Initiation and promotion in hepatocarcinogenesis.
    Schulte-Hermann R
    Arch Toxicol; 1987; 60(1-3):179-81. PubMed ID: 3304207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.